Mixed Mucinous Carcinoma Of The Breast In Young Female Patient: Case Report

Mucinous carcinoma of the breast, also known as colloid carcinoma, is a rare histological form characterized by abundant mucin production. It accounts for only 1–7% of all infiltrating carcinomas of the breast. It has a better prognosis than the usual ductal breast carcinoma, with 90% survival at 10 years and a higher incidence in peri- and post-menopausal patients. Fewer cases have been reported in younger patients. Based on the presence or absence of concomitant areas with typical infiltrating ductal carcinoma, it can be classified as pure or mixed mucinous. However, it is important to note that the pure mucinous type has a better prognosis than the mixed type. Histopathology is confirmatory in all cases. The primary protocol of treatment for patients suffering from mucinous breast carcinoma is surgery with post-operative adjuvant treatment: radiotherapy, chemotherapy, and endocrine therapy.

Here, we present the case of a 29-year-old female patient presented with left breast swelling of 2 years duration who was found to have mixed mucinous breast carcinoma and was treated with modified radical mastectomy and chemotherapy. To our knowledge, there is no similar case reported in our country, and there are few case reports worldwide with the diagnosis of mixed mucinous carcinoma at a young age.

Current perspectives of oncoplastic breast surgery in Pakistan

Oncoplastic breast surgery is based on the concept of tumour-specific immediate reconstruction. It combines both local and distant techniques to maintain breast texture, symmetry and cosmesis without compromising oncological outcome. The current narrative review was planned to highlight the current state and future of oncoplastic breast surgery in low- and middle-income
countries where its utilisation in surgical practice remains insubstantial because majority of the surgeons who are treating breast cancer are either general surgeons or breast surgeons who do not have expertise in oncoplastic breast surgery or reconstructive surgery. Moreover, scarcity of financial resources, ignorance about oncoplastic breast surgery techniques, disfigurement
distress and cultural taboos coerce women to hide in the shadows with their breast disease. Oncoplastic breast surgery needs more exposure in a developing country like Pakistan.

Is Quality of Life After Mastectomy Comparable to That After Breast Conservation Surgery? A 5-year Follow Up Study From Mumbai, India

Purpose
Breast cancer is the commonest cancer in women worldwide. Surgery is a central part of the treatment. Modified radical mastectomy (MRM) is often replaced by breast conserving therapy (BCT) in high-income countries. MRM is still the standard choice, in low- and middle-income countries (LMICs) as radiotherapy, a mandatory component of BCT is not widely available. It is important to understand whether quality of life (QOL) after MRM is comparable to that after BCT. This has not been studied well in LMICs. We present, 5-year follow-up of QOL scores in breast cancer patients from India.

Methods
We interviewed women undergoing breast cancer surgery preoperatively, at 6 months after surgery, and at 1 year and 5 years, postoperatively. QOL scores were evaluated using FACT B questionnaire. Average QOL scores of women undergoing BCT were compared with those undergoing MRM. Total scores, domain scores and trends of scores over time were analyzed.

Results
We interviewed 54 women with a mean age of 53 years (SD 9 ± years). QOL scores in all the women, dipped during the treatment period, in all subscales but improved thereafter and even surpassed the baseline in physical, emotional and breast-specific domains (p < 0.05) at 5 years. At the end of 5 years, there was no statistically significant difference between the MRM and BCT groups in any of the total or domain scores.

Conclusion
QOL scores in Indian women did not differ significantly between MRM and BCT in the long term. Both options are acceptable in the study setting.